Fig. 1
From: Depleting TMED3 alleviates the development of endometrial carcinoma
Overexpression of TMED3 in EC tissues and construction of TMED3-knockdown cell models. A Bioinformatic analysis derived from The Cancer Genome Atlas (TCGA) database revealed higher expression of TMED3 in EC tissues than that in normal endometrium issues. B The representative photos of para-carcinoma tissues and EC tissues deposed by IHC. C The knockdown efficiencies of three shTMED3-harboring lentiviruses in ishikawa cells. D The fluorescence images indicating high efficiency of lentivirus transfection (> 80%) and the relative mRNA levels of TMED3 in experimental HEC-1-B and ishikawa cells after treated by shCtrl-/shTMED3-harboring lentivirus detected by qRT-PCR. E The expression level of TMED3 protein in shCtrl-/shTMED3-harbroing cells of both cell lines. The scale bar is 50 μm long. *P < 0.05, **P < 0.01, ***P < 0.001